Medicare Ups Provider Incentive for Prediabetes Intervention
Providers may now be paid up to $785 (increased from $450) for each patient who loses 5% of their body weight.
Interesting T2DM: ED, Early Menopause and Diabetes Risk
A top-line look at the latest news: novel risk factors, insulin vs insulin; and predictors of weight loss success.
Quiz: The 2017 AACE/ACE Lipid Management and CVD Prevention Guidelines
The 2017 lipid management guidelines have met both accolades and controversy. Take our quick quiz on the updates.
New Schedule Proposed for Diabetic Retinopathy Screening
This screening model may improve retinopathy detection in patients with T1DM and decrease costs.
Interesting T2DM: FDA News & Diabetes Risk
Our May list includes an app for titration of basal insulin, GI effects of GLP-1 agonists, and lifestyle intervention studies.
Endo News Roundup: Diabetic Retinopathy
April news highlights the importance of timely eye examinations in young patients with diabetes and the efficacy of a teleretinal screening program.
Interesting T2DM: Pharmacotherapy & Obesity Outcomes
Our April list includes CV events with DPP-4 or SGLT2 inhibitors vs. insulin, and impact of obesity on nonalcoholic fatty liver disease and thyroid function.
Diabetes & Ethnicity: Potential Life Years Lost
What role, if any, does ethnicity play in potential life years lost in patients with diabetes?
Statin Therapy with Type 2 Diabetes & Nephropathy
In patients with type 2 diabetes complicated by nephropathy, what is the real life effect of statin therapy on cardiovascular disease prevention?
CV Risks and Diabetes: Puerto Rican Population
Dr. Bobby Lazzara discusses a study looking at certain demographics and cardiovascular complications in a diabetic patient population in Puerto Rico.
Microvascular Disease Burden in Type 2 Diabetes
Does microvascular disease burden predict future cardiovascular events in type 2 diabetes? Dr. Bobby Lazzara discusses this question.
By clicking Accept, you agree to become a member of the UBM Medica Community.